EIF3B and breast carcinoma: In contrast, low EIF3B /C /E/ F/ H/ J/ K expression were related to poorer prognosis in breast cancer (Figure 3(c), HR = 1.29, 95% CI: 1.16–1.44, P < 0.001; Figure 3(d), HR = 1.29, 95% CI: 1.15–1.43, P < 0.001; Figure 3(e), HR = 1.32, 95% CI: 1.19–1.48, P < 0.001; Figure 3(f), HR = 1.13, 95% CI: 1.01–1.26, P < 0.001; Figure 3(g), HR = 1.18, 95% CI: 1.05–1.31, P < 0.001; Figure 3(i), HR = 1.49, 95% CI: 1.33–1.66, P < 0.001; Figure 3(j), HR = 1.18, 95% CI: 1.06–1.32, P < 0.01).